Elanco Animal Health Incorporated

NYSE:ELAN

17.35 (USD) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1,2411,1931,0201,0301,1841,2051,0351,0681,0571,2579881,0261,1751,2261,1131,1311,2791,2421,139.7889.6586.3657.7787771.3781.6731.1799.3761.1770.2736.2754.3697.1718.8718.8
Cost of Revenue 664637631625626648654627570628578600617646651643680716759.9537.4344.9384.3461.5411.1405.3392.8462.6418.5480.9409.2405376.2343.1343.1
Gross Profit 577556389405558557381441487629410426558580462488599526379.8352.2241.4273.4325.5360.2376.3338.3336.7342.6289.3327349.3320.9375.7375.7
Gross Profit Ratio 0.4650.4660.3810.3930.4710.4620.3680.4130.4610.50.4150.4150.4750.4730.4150.4310.4680.4240.3330.3960.4120.4160.4140.4670.4810.4630.4210.450.3760.4440.4630.460.5230.523
Reseach & Development Expenses 929481878987798681818078828192949489112.788.159.466.867.369.968.864.161.158.961.465.26261.963.9563.95
General & Administrative Expenses 0000000000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000000
SG&A 400341300323354337292313353327303298343323327342385348374.1277.7162.8182185.9192.3200.9181.1185.1179191.1180196.8194.7194.2194.2
Other Expenses 00000000000000000000000000000001.900
Operating Expenses 492435381410443424371399434408383376425404419436479437486.8365.8222.2248.8253.2262.2269.7245.2246.2237.9252.5245.2319308.2409.7409.7
Operating Income 851218-51151331042532212750133176435212089-107-13.619.224.672.398106.693.190.5104.736.881.830.312.762.8562.85
Operating Income Ratio 0.0680.1010.008-0.0050.0970.110.010.0390.050.1760.0270.0490.1130.1440.0390.0460.0940.072-0.094-0.0150.0330.0370.0920.1270.1360.1270.1130.1380.0480.1110.040.0180.0870.087
Total Other Income Expenses Net -60-61-59564-147-121-137-1,139-132-113-115-94-147-101-162-182-356-169-211.1-195.4-96.3-92.4-76.6-110.5-56.4-48.3-92.7-25.9-76.8-4.3-185.7-21.8-96.85-96.85
Income Before Tax 2560-51559-3212-127-1,097-79108-88-44-1475-119-130-236-80-318.1-209-77.1-67.8-4.3-12.550.244.8-2.278.8-4077.5-155.4-9.1-34-34
Income Before Tax Ratio 0.020.05-0.050.543-0.0270.01-0.123-1.027-0.0750.086-0.089-0.043-0.0120.061-0.107-0.115-0.185-0.064-0.279-0.235-0.132-0.103-0.005-0.0160.0640.061-0.0030.104-0.0520.105-0.206-0.013-0.047-0.047
Income Tax Expense 14-7-4319518-2014-1185-3421-424-15-26-26-194.7-74-23.9-18.75.2-22.514.313.3-18.618.622.84.86.111.630.2530.25
Net Income 1167-8364-5032-141-1,096-97103-54-65-1051-104-104-210-61-322.8-135-53.2-49.1-9.51035.931.516.460.2-62.872.7-161.5-20.7-64.25-64.25
Net Income Ratio 0.0090.056-0.0080.353-0.0420.027-0.136-1.026-0.0920.082-0.055-0.063-0.0090.042-0.093-0.092-0.164-0.049-0.283-0.152-0.091-0.075-0.0120.0130.0460.0430.0210.079-0.0820.099-0.214-0.03-0.089-0.089
EPS 0.0220.14-0.0160.74-0.10.065-0.29-2.22-0.20.21-0.11-0.133-0.0210.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0260.0270.10.090.040.16-0.180.2-0.45-0.057-0.18-0.18
EPS Diluted 0.0220.13-0.0160.73-0.10.065-0.29-2.22-0.20.21-0.11-0.133-0.0210.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0250.0270.10.090.040.16-0.180.2-0.44-0.057-0.18-0.18
EBITDA 264274175814195244111-8522013491461832253061381001301-34.7-28.628.736.297.884.9140.2148.792.5151.535.3151.8117.487.9140.9140.9
EBITDA Ratio 0.2130.230.1720.790.1650.2020.107-0.7980.190.2780.1480.1780.1910.250.1240.0880.0010.242-0.03-0.0320.0490.0550.1240.110.1790.2030.1160.1990.0460.2060.1560.1260.1960.196